[HTML][HTML] Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for …

P Liu, C Dong, H Shi, Z Yan, J Zhang… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background To investigate the prognostic significance of N7-methylguanosine (m7G)
regulators and immune infiltration in liver hepatocellular carcinoma (LIHC). Methods The …

N7-Methylguanosine regulatory genes profoundly affect the prognosis, progression, and antitumor immune response of hepatocellular carcinoma

K Zhou, J Yang, X Li, W Xiong, P Zhang… - Frontiers in surgery, 2022 - frontiersin.org
Background Hepatocellular carcinoma (HCC) is a common abdominal cancer with poor
survival outcomes. Although there is growing evidence that N7-methylguanosine (m7G) is …

Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …

T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …

N7-Methylguanosine genes related prognostic biomarker in hepatocellular carcinoma

P Regmi, ZQ He, T Lia, A Paudyal, FY Li - Frontiers in genetics, 2022 - frontiersin.org
Background: About 90% of liver cancer-related deaths are caused by hepatocellular
carcinoma (HCC). N7-methylguanosine (m7G) modification is associated with the biological …

A m6A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma

S Xu, Y Zhang, Y Yang, K Dong, H Zhang… - Frontiers in …, 2024 - frontiersin.org
Background Increasing evidence have highlighted the biological significance of mRNA N6-
methyladenosine (m6A) modification in regulating tumorigenicity and progression. However …

Identification and validation of a prognostic prediction model of m6A regulator-related LncRNAs in hepatocellular carcinoma

C Jin, R Li, T Deng, J Li, Y Yang, H Li… - Frontiers in Molecular …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …

N6-Methyladenine-Related signature for immune microenvironment and response to immunotherapy in hepatocellular carcinoma

S Ren, Y Qin, H Qin, H Wang, G Li, Y Zhu… - … Journal of General …, 2022 - Taylor & Francis
Background The prognostic value of m6A-related genes in hepatocellular carcinoma (HCC)
and its correlation with the immune microenvironment still requires further investigation …

Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma

YL Peng, YF Dong, LL Guo, MY Li, H Liao, RS Li - Plos one, 2023 - journals.plos.org
Background N7-methylguanosine (m7G) is one of the most common RNA posttranscriptional
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …

A novel m6A‐related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients

S Xie, Y Wang, J Huang, G Li - IET Systems Biology, 2022 - Wiley Online Library
Liver hepatocellular carcinoma (LIHC) comprises most cases of liver cancer with a poor
prognosis. N6‐methyladenosine (m6A) plays important biological functions in cancers …

The m6A/m5C/m1A regulated gene signature predicts the prognosis and correlates with the immune status of hepatocellular carcinoma

D Li, K Li, W Zhang, KW Yang, DA Mu… - Frontiers in …, 2022 - frontiersin.org
RNA modification of m6A/m5C/m1A contributes to the occurrence and development of
cancer. Consequently, this study aimed to investigate the functions of m6A/m5C/m1A …